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To explore the global mechanisms of estrogen-regulated transcription, we used chromatin immunoprecipi-
tation coupled with DNA microarrays to determine the localization of RNA polymerase II (Pol II), estrogen
receptor alpha (ER), steroid receptor coactivator proteins (SRC), and acetylated histones H3/H4 (AcH) at
estrogen-regulated promoters in MCF-7 cells with or without estradiol (E2) treatment. In addition, we
correlated factor occupancy with gene expression and the presence of transcription factor binding elements.
Using this integrative approach, we defined a set of 58 direct E2 target genes based on E2-regulated Pol II
occupancy and classified their promoters based on factor binding, histone modification, and transcriptional
output. Many of these direct E2 target genes exhibit interesting modes of regulation and biological activities,
some of which may be relevant to the onset and proliferation of breast cancers. Our studies indicate that about
one-third of these direct E2 target genes contain promoter-proximal ER-binding sites, which is considerably
more than previous estimates. Some of these genes represent possible novel targets for regulation through the
ER/AP-1 tethering pathway. Our studies have also revealed several previously uncharacterized global fea-
tures of E2-regulated gene expression, including strong positive correlations between Pol II occupancy and AcH
levels, as well as between the E2-dependent recruitment of ER and SRC at the promoters of E2-stimulated
genes. Furthermore, our studies have revealed new mechanistic insights into E2-regulated gene expression,
including the absence of SRC binding at E2-repressed genes and the presence of constitutively bound,
promoter-proximally paused Pol IIs at some E2-regulated promoters. These mechanistic insights are likely to
be relevant for understanding gene regulation by a wide variety of nuclear receptors.
Signal-regulated transcriptional responses are an important
means by which cells respond to physiological and environ-
mental cues. These responses typically involve the direct or
indirect activation or inhibition of site-specific DNA-binding
transcription factors, which mediate their effects by binding to
cognate regulatory sites across the genome. Steroid hormone
receptors, such as estrogen receptor alpha (ER), represent a
class of signal-activated DNA-binding transcription factors
that respond to small-molecule ligands, such as estrogens (35).
Estrogens and other steroid hormones act through their recep-
tors to control patterns of gene expression that specify distinct
physiological outcomes, including aspects of reproduction, de-
velopment, and metabolism (13, 40). Estrogens also play key
roles in many disease states, including breast and uterine can-
cers as well as osteoporosis (14). Understanding how such
cellular signaling events lead to specific gene regulatory re-
sponses and physiological outcomes is a fundamental question
in biology.
The binding of signal-regulated transcription factors to reg-
ulatory sites (i.e., enhancers and silencers) across the genome
ultimately regulates the recruitment and/or activity of RNA
polymerase II (Pol II) at target promoters, thus regulating the
transcription of those promoters (see Fig. 1A for an example).
In cases of transcriptional activation, the recruitment of a va-
riety of coactivator proteins by DNA-bound transcription fac-
tors opens the chromatin structure and stabilizes Pol II binding
at the promoter, leading to increased gene transcription (39).
In cases of transcriptional repression, the recruitment of core-
pressor proteins directs the formation of repressive chromatin
structures or transcription complexes that inhibit the recruit-
ment and activation of Pol II at the promoter (19). The mul-
tistep process of (i) signal-regulated transcription factor
binding to enhancers/silencers, (ii) coactivator/corepressor re-
cruitment and activity, and (iii) Pol II recruitment/dissociation
and activation/inhibition provides many opportunities for ex-
quisite regulatory control that directs global transcriptional
responses (19, 39). Although the underlying mechanisms of
signal-regulated transcription factor binding at cognate genomic
sites have been well characterized, the specific mechanisms con-
necting transcription factor activity at enhancers to Pol II recruit-
ment and activation at target promoters across the genome are
less well understood.
A number of recent studies have examined the binding of
signal-regulated transcription factors, including E2Fs, HNFs,
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Sp1, c-Myc, p53, and ER, to regulatory sites across the ge-
nome using the powerful combination of chromatin immuno-
precipitation (ChIP) coupled with DNA microarrays (a “ChIP-
chip” approach) (50). These studies have provided a global
view of transcription factor binding that was lacking from pre-
vious gene-by-gene analyses. Studies with estrogen-bound
ER have shown that, for many estrogen-regulated genes, the
receptor binding sites are located at great distances (100
kilobase pairs) from the target promoters, while for other
genes the receptor binding sites are located within or near the
proximal promoter regions (9–11, 23, 29, 31) (Fig. 1A). These
sites include both direct ER-binding sites (i.e., estrogen re-
sponse elements [EREs]) and tethering sites (e.g., AP-1, Sp1,
and NF-B sites). In contrast to the genomic localization of
ER, much less is known about how ER binding events at
promoter-proximal or promoter-distal enhancers lead to estro-
gen-dependent changes in Pol II occupancy at target promot-
ers and the regulation of gene expression.
In the studies described herein, we used ChIP-chip with a
custom genomic microarray to explore how estrogen signaling
affects factor recruitment and histone modification at estrogen-
regulated promoters across the genome in MCF-7 human
breast cancer cells. Specifically, we compared the occupancy of
Pol II to the binding of ER and steroid receptor coactivator
(SRC) proteins, acetylation of nucleosomal histones, and tran-
scriptional output from target promoters. The results from our
ChIP-chip experiments extend beyond previous ER genomic
localization experiments by (i) examining the ligand-depen-
dent localization of a non-DNA-binding nuclear receptor co-
factor (i.e., SRC), (ii) examining the genomic location of four
different types of factors simultaneously (i.e., ER [a DNA-
binding factor], SRC [a non-DNA-binding coregulator], his-
tone acetylation [a histone mark], and Pol II), (iii) determining
the patterns of localization in both the presence and absence of
estradiol (E2), and (iv) correlating patterns of genomic local-
ization with functional output, namely, Pol II recruitment and
transcription from target promoters. Our results have allowed
us to classify the estrogen-regulated promoters in MCF-7 cells
based on factor binding, histone modification, and transcrip-
tional output. Furthermore, examination of both estrogen-
treated and untreated conditions has revealed novel mechanis-
tic aspects of ligand-regulated gene expression by ER.
Collectively, our results provide new insights into the transcrip-
tional networks controlling estrogen-regulated gene expres-
sion.
MATERIALS AND METHODS
Additional information about the materials and methods is available at http:
//mbg.cornell.edu/cals/mbg/research/kraus-lab/sm.cfm.
ChIP assays. ChIPs for ER, Pol II, the Pol II serine 2 (Ser2)-phosphorylated
C-terminal domain, SRC, c-Fos, NELFA (a negative elongation factor [NELF]
subunit), and acetylated histones H3 and H4 (AcH) were performed using
MCF-7 cells grown in estrogen-free medium essentially as described previously
(1, 45). The resulting ChIP DNA material was used to probe custom promoter
arrays as described below or in gene-specific quantitative real-time PCR (qPCR)
analyses.
ChIP-chip. A custom spotted estrogen-regulated promoter array was designed
and produced using approaches described previously (41, 43). ChIP DNA was
blunted using T4 DNA polymerase, ligated to linkers, and amplified using liga-
tion-mediated PCR, as described previously (43). The amplified DNA was la-
beled with Cy3 or Cy5 fluorophores by use of a Bioprime random primer labeling
kit (Invitrogen) and then used to hybridize the promoter arrays as described
FIG. 1. Regulation of RNA Pol II occupancy by E2 at target promoters in MCF-7 cells. (A) Schematic representation of short-range and
long-range regulation of RNA Pol II by liganded ER. Changes in the recruitment or activity of RNA Pol II complexes at the promoter represent
the functional outcomes of liganded ER binding to its cognate enhancers across the genome. TFIID, transcription factor IID. (B) RNA Pol II
genomic location analysis by ChIP-chip in MCF-7 cells. Data from all the filtered elements on the custom estrogen-regulated promoter array are
represented by heat maps. The relative occupancy of each genomic fragment by RNA Pol II with or without E2 treatment is shown in the blue/white
scale, whereas the change (n-fold) of RNA Pol II occupancy upon E2 treatment is shown in the red/green scale. The expanded images on the right
highlight some of the interesting classes of genes shown in panel C. (C) Classification of RNA Pol II binding sites. Each quadrant in the graphical
representation indicates the number of filtered elements from the array exhibiting one of four different patterns of RNA Pol II occupancy (e.g.,
for class II, low occupancy, E2; high occupancy, E2).
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previously (41, 43); details on the modifications are available at http://mbg
.cornell.edu/cals/mbg/research/kraus-lab/sm.cfm. Washed arrays were scanned
using a GenePix 4000B scanner (Axon), and the data were collected using the
GenePix Pro 6.0 software (Axon).
Statistical methods for ChIP-chip and ChIP-expression analyses. Statistical
analyses were performed using the statistical software R (GNU project; Free
Software Foundation); all the scripts that were used are available on request.
After the spots flagged for bad quality were filtered out, the signal ratio of
immunoprecipitated DNA over input DNA was log2 transformed and normal-
ized based on a set of control genes; descriptions are available at the URL noted
above. For each factor studied, the change (n-fold) between untreated and
E2-treated cells was calculated and log2 transformed. Analysis of variance was
performed across all the replicates, and a nominal P value threshold of0.05 was
used to select promoters for further analyses. In addition to the P value thresh-
old, a log2 change (n-fold) threshold of 0.37 was used to select target promot-
ers. Promoters that passed both the P value and change (n-fold) thresholds were
classified as target sites where the factor occupancy changed upon E2 treatment.
Based on standard ChIP-qPCR experiments, our estimated false-positive error
rate using the thresholds described above was 9% (number of genes tested 
30). To identify target promoters where ER or RNA Pol II was localized in both
untreated and E2-treated cells, we performed a median percentile rank analysis
as described previously (7). Hierarchical clustering of the data was performed
using the Cluster software and visualized using the Treeview software (16). For
the correlation analyses, Spearman’s rank correlation coefficients were calculated
using data that passed the P value threshold as described above. The data for all
the factors and genomic regions studied are available at the URL noted above.
DNA sequence analyses. Each DNA sequence on the array was scanned for the
presence of EREs and AP-1 binding elements using position weight matrices
obtained from the TRANSFAC database (accession numbers M00174 and
M00517, respectively) using approaches described in detail at the URL noted
above.
Transient transfection reporter gene assays. MCF-7 cells grown in estrogen-
free medium were transfected with the following combination of plasmid DNAs:
(i) 1 	g of a luciferase reporter construct containing either the native UGT2B15
promoter (spanning the region from 449 bp to 114 bp) or the native
UGT2B15 promoter with a deletion of the AP-1 binding element and (ii) 600 ng
of pCMV
, a constitutive 
-galactosidase expression vector used to normalize
for transfection efficiency. The transfected cells were treated with or without 10
nM E2 for 16 h and then assayed for luciferase activity and 
-galactosidase
activity.
RNA extraction and reverse transcription-qPCR. Total RNA was isolated
from MCF-7 cells grown in estrogen-free medium by using RNeasy columns
(QIAGEN). cDNA prepared from each sample was analyzed by qPCR in a
real-time PCR thermocycler under standard conditions.
Expression microarray analyses. Total RNA was isolated from MCF-7 cells
grown in estrogen-free medium by using TRIzol reagent (Invitrogen) followed by
RNeasy columns (QIAGEN). Seven micrograms of total RNA was subjected to
one-cycle target labeling assay (Affymetrix) to generate biotinylated cRNA tar-
gets for hybridization to Affymetrix U133A 2.0 microarray under standard con-
ditions. The raw data from three independent replicates were processed by
Affymetrix GCOS software to obtain detection calls and signal values and then
normalized by scaling. Only probe sets having “present” calls on at least two of
the three arrays were included for further analysis; those signals were log2
transformed and median centered. The t test was applied to the normalized data
matrix to identify differential genes between the E2-treated and untreated con-
trol samples.
RESULTS
Regulation of RNA Pol II occupancy by E2 at target pro-
moters. To understand the specific mechanisms connecting
transcription factor activity at enhancers to Pol II recruitment
and activation at target promoters, we examined E2-regulated
transcriptional responses (i.e., factor binding, histone modifi-
cation, and transcriptional output) in ER-positive MCF-7
human breast cancer cells. As an initial functional readout, we
examined the localization of Pol II at estrogen-regulated pro-
moters in response to E2 treatment using ChIP-chip with a
custom promoter microarray. Since previous studies have dem-
onstrated that Pol II is a good marker for transcriptionally
active promoters (3, 21), our expectation was that E2-bound
ER would alter the occupancy of Pol II at the promoters of
estrogen-regulated genes whether or not the ER-binding reg-
ulatory site was located in the proximal promoter or at a great
distance from the promoter (Fig. 1A). A key aspect of this
work not addressed in most of the previous ER ChIP-chip
studies is the examination of both the E2 and E2 condi-
tions during the genomic discovery phase of the work (as
opposed to the gene-specific confirmation phase). This allowed
us to study on a global scale a wider variety of modes for
E2-regulated transcription, including (i) E2-dependent repres-
sion and (ii) E2-independent constitutive binding of Pol II at
E2-regulated promoters.
For our ChIP-chip studies, we produced a custom spotted
genomic microarray containing 900 human genomic regions
(1 kb each), including 600 estrogen-regulated promoters,
250 control promoters, and 50 nonpromoter regions. Each
promoter was represented by a DNA fragment spanning ca.
800 to 200 bp relative to the transcription start site (TSS),
and some of the promoters were tiled in 1-kb fragments over
a 12-kb region surrounding the TSS. The estrogen-regulated
promoters were selected based on (i) previous expression mi-
croarray studies, (ii) bioinformatic analyses, and (iii) previous
gene-by-gene studies. The promoters included those from es-
trogen up-regulated and down-regulated genes, as well as
genes whose regulation by estrogens is cell type specific. We
also included 12 previously characterized nonpromoter ER-
binding regions on the array (9). Overall, our approach pro-
vided coverage of more than 50 percent of the E2-regulated
transcriptome in MCF-7 cells under the conditions tested (see
below).
MCF-7 cells were treated with ethanol or E2 for a short time
(i.e., 45 min) so that target promoters most likely directly
regulated by E2, not through secondary effects, could be iden-
tified. Genomic DNA fragments bound by Pol II were isolated
by ChIP, the immunoprecipitated DNA was hybridized to the
genomic microarray, and the data were analyzed as shown in
Fig. 1B. A number of controls to ensure experimental fidelity
in the ChIP-chip experiments were also performed (e.g., mock
ChIP hybridization, dye swapping; data not shown). Our data
analysis protocol allowed us to determine the relative levels of
Pol II in the absence and presence of E2 treatment (“Occu-
pancy” in Fig. 1B), as well as the change (n-fold) in Pol II
occupancy upon E2 treatment (“Fold” in Fig. 1B). We then
used these analyses to classify the promoters based on the
patterns of Pol II localization.
We identified 47 promoters where the occupancy of Pol II
increased upon E2 treatment (classified as class II promoters)
and 16 promoters where the occupancy of Pol II decreased
upon E2 treatment (class IV promoters) (Fig. 1B and C). We
also identified 66 promoters that were occupied by Pol II both
in the presence and absence of E2 treatment (class III pro-
moters), many but not all of which are well-characterized
housekeeping genes that are not regulated by E2. Finally, we
identified a group of 534 promoters that were not occupied by
Pol II in either the presence or the absence of E2 treatment
(class I). The vast majority of the class I promoters represent a
group of genes that are not directly regulated by E2 in MCF-7
cells under the experimental conditions that we used (see be-
low). Our results using Pol II as an endpoint of E2 signaling are
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consistent with previous gene expression studies showing that,
in MCF-7 cells, more than 100 genes are regulated more than
twofold after a 4-hour treatment with E2, and most of these
genes are up-regulated (18).
Classification of direct E2 target genes. Our initial Pol II
ChIP-chip experiments conducted in the absence and presence
of E2 allowed us to define a set of 58 direct E2 target genes
based on E2-dependent changes in Pol II promoter occupancy
(and mRNA expression; see below), as opposed to inferences
from bioinformatics and statistical analyses or correlations with
RNA expression alone (a more detailed description of how the
direct E2 target genes were defined is available at http://mbg
.cornell.edu/cals/mbg/research/kraus-lab/sm.cfm. The use of both
a short E2 treatment (i.e., 45 min.) and aE2 condition, which
was lacking in previous ChIP-chip analyses (9, 10, 23, 29, 31)
(see Table S1 at the URL noted above), is required for this
type of classification. While direct regulation by E2 of a num-
ber of the target genes on our array has been demonstrated
previously (e.g., the TFF1 gene, also known as pS2), our stud-
ies using the Pol II-based criteria noted above have confirmed
FIG. 2. Cooccupancy of RNA Pol II and ER at target promoters in MCF-7 cells. (A) ER genomic location analysis by ChIP-chip in MCF-7
cells. Data from all of the elements on the custom estrogen-regulated promoter array are represented by heat maps, as described for RNA Pol
II in Fig. 1B. The expanded images on the right highlight the “class A” regions shown in panel C and constitutively ER-bound promoters.
(B) Correlation between ER and RNA Pol II occupancy at estrogen-regulated promoters. The relative change in factor occupancy is defined as
the log2 change (n-fold) in occupancy upon E2 treatment as a percentage of the maximum log2 change (n-fold) observed for each factor. The red
data points show the data from a collection of promoters for which estrogen-dependent ER recruitment correlates positively with RNA Pol II
recruitment (correlation coefficient  0.43 [P  0.0001]). The blue data points show the data from a collection of promoters for which
estrogen-dependent ER recruitment correlates negatively with RNA Pol II recruitment (correlation coefficient  0.53 [P  0.0283]). All
elements from the promoter array showing significant E2-dependent enrichment (P  0.05) were included in the analysis. (C) Classification of
ER-binding sites based on RNA Pol II occupancy. The class A regions (within the circle) include 47 sites where ER is recruited upon E2
treatment, 37 of which are gene promoters. The class B regions are those for which no ER recruitment was observed. The distribution of the class
A and B regions is superimposed on the representation of the RNA Pol II classes I, II, III, and IV from Fig. 1C. (D) ChIP-chip tiling for the TFF1
and EBAG9 genes. Occupancy, expressed as ChIP enrichment ratios (IP/input), for ER and RNA Pol II throughout the indicated genomic region
is shown in the absence (-U) or presence (-E) of E2. “0” represents the annotated TSS; regions upstream of the TSS are indicated by negative
numbers.
VOL. 27, 2007 GENOMIC ANALYSES OF ESTROGEN-REGULATED GENES 5093
 o
n
 January 14, 2015 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
an additional set of more than 40 direct E2 target genes (see
Fig. 3A; see also Fig. S2 and Table S1 at the URL noted
above). These include UGT2B15, NBPF15, PRUNE, SLC27A2,
HSPB8, and FACVL1, which are involved in processes such as
xenobiotic metabolism, fatty acid transport, and protein chaper-
oning. The identification of direct (as opposed to secondary) E2
target genes is an important step in understanding early E2-
dependent gene regulatory responses.
Correlation between ER binding at enhancer sites and
RNA Pol II recruitment to target promoters. Previous gene-
by-gene studies using model estrogen-regulated genes have
shown that E2-dependent changes in Pol II promoter occu-
pancy correlate with the binding of ER to estrogen-respon-
sive enhancers located in the promoters or distal regulatory
regions of the genes (15, 37, 45). In this regard, we examined
which Pol II-bound promoters were also bound by ER. In
addition, we examined ER binding to a small subset of pre-
viously characterized distal enhancers. We performed ChIP-
chip with our custom promoter array to determine the relative
levels of ER in the absence or presence of E2 treatment
(“Occupancy” in Fig. 2A) as well as the change (n-fold) in ER
occupancy upon E2 treatment (“Fold” in Fig. 2A). We iden-
tified 47 genomic regions where ER was recruited upon E2
treatment (classified as class A genomic sites, as opposed to
class B genomic sites, where no ER recruitment was ob-
served) (Fig. 2A). Of the 47 class A sites, 37 were in gene
promoters (i.e., within 1 kb from the TSS), while the remaining
10 were located at greater distances (i.e., 5 to 400 kb) from the
nearest known gene (Table 1). Interestingly, we also identified
eight promoters that were occupied by ER in both the pres-
ence and the absence of E2 (Fig. 2A and data not shown).
To examine the relationship between Pol II and ER bind-
ing at target gene promoters, the results for ER binding were
compared with the results obtained for Pol II. Spearman rank
correlation analysis revealed two distinct types of correlation
between Pol II and ER localization at target gene promoters
(Fig. 2B). The first is a significant positive correlation between
ER and Pol II occupancy at a set of cooccupied promoters
upon E2 treatment (Fig. 2B; correlation coefficient 0.43, P
0.0001). This result is consistent with previous studies showing
that the recruitment of ER to target promoters promotes the
recruitment of the Pol II machinery to those promoters (15, 37,
45). The second is a significant negative correlation between
ER and Pol II occupancy at a smaller set of promoters upon
E2 treatment (Fig. 2B; correlation coefficient  0.53 [P 
0.0283]). This finding is consistent with studies showing that for
certain estrogen-regulated genes, ER recruitment represses
gene expression (36, 49), although the associated mechanisms
are not yet fully understood.
To analyze further which Pol II-bound promoters were
bound by ER upon E2 treatment, we examined how the class
A (i.e., ligand-dependent) ER-binding sites were distributed
among the class I, II, III, and IV Pol II binding sites (Fig. 2C).
ER was recruited to about half of the promoters to which Pol
II was recruited upon E2 treatment (class IIA; 22 out of 47),
whereas no ER binding was detected at the rest of these
promoters (class IIB). Moreover, ER was recruited to 4 pro-
moters from which Pol II was released upon E2 treatment
(class IVA), whereas no ER binding was detected at the other
12 promoters (class IVB). These results reflect the ability of
ER to regulate its target genes by binding either at proximal
promoters (classes IIA and IVA) or at enhancers located out-
side of the promoter regions (classes IIB and IVB) (10, 29, 31,
37). Interestingly, ER was also recruited in an E2-dependent
manner to four promoters that were occupied by Pol II both in
the presence and absence of E2 (class IIIA). Such an obser-
vation is consistent with the presence of a constitutively bound
“paused” Pol II that is not productively engaged in transcrip-
tion until the recruitment and activation of ER by E2 (44; see
Fig. 6C and 7 below). Finally, ER was recruited in an E2-
dependent manner to 17 promoters where no Pol II binding
was observed (class IA). For these genes, many of which show
E2-dependent regulation of expression (see Fig. 6C below), the
detection of Pol II may fall below the limit of sensitivity of our
ChIP-chip assay. Alternatively, Pol II may not be detected at
these promoters due to rapid movement into the body of the
TABLE 1. Factor binding to nonpromoter regions and E2-dependent regulation of the nearest neighboring genes
Cluster
no.a
Binding
sitea
Chromosomal
location
Enhancer bindingb Nearest
genec
Distance
(kb)c
Promoter bindingb Gene
expressiondER Pol II SRC AcH ER Pol SRC AcH
3 Blk3 21 15171656     NRIP1 83.2     
4 Blk4 15467150     NRIP1 226     
Blk5 15493593    
Blk7 15503950    
13 Blk21 40606306     PCP4 386     
Blk22 40609671    
16 Blk32 42680784     TMPRSS3 4.80     
Blk33 42690200    
23 Blk42 22 19822950     SLC7A4 172     ND
Blk44 19943560    
24 Blk45 27534171     XBP1 15.5     
Blk46 27539034    
a The binding sites are those defined by Carroll et al. (9) and are listed using their nomenclature. These binding sites can be grouped in six distinct clusters based
on their chromosome location.
b The binding of ER, Pol II, SRC, and AcH at the designated enhancer and promoter regions in MCF-7 cells were determined by ChIP-chip and ChIP-qPCR,
respectively.  indicates a 1.5-fold increase following E2 treatment;  indicates a 1.5-fold increase following E2 treatment.
c The nearest gene to each cluster and the distance between the gene and the center of the cluster are listed.
d The change in gene expression following E2 treatment was determined by expression microarray analysis.  indicates a 1.5-fold increase following E2 treatment; 
indicates a 1.5-fold increase following E2 treatment. ND indicates that no transcript was detectable.
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gene. The recruitment of ER and Pol II to promoters was
generally consistent with the expression of the associated genes
(see Fig. 6B and C; also see Fig. S5C at http://mbg.cornell.edu
/cals/mbg/research/kraus-lab/sm.cfm). Collectively, our studies
indicate that the pattern of ER and Pol II binding at E2-
regulated promoters, which is more complicated than previ-
ously realized, can be used to group the promoters into mech-
anistically distinct classes.
We also examined the relationship between ER binding to
distal enhancers and Pol II recruitment to the nearest neigh-
boring promoters. Of the 12 previously characterized nonpro-
moter ER-binding regions included on the ChIP-chip array,
10 showed detectable binding of ER in response to E2 and
were classified as class A (i.e., ligand-dependent) ER-binding
sites (Table 1). These 10 nonpromoter class A sites correspond
to six different enhancer clusters, each presumably controlling
the expression of a neighboring gene (Table 1). The E2-de-
pendent recruitment of ER to the enhancer clusters corre-
lated with Pol II recruitment to the nearest neighboring pro-
moter, as well as expression of the associated gene, in four out
of the six cases examined (Table 1). However, in two out of the
six cases examined, ER recruitment to the distal enhancer did
not appear to regulate the nearest neighboring promoter. In
many cases, Pol II was also detected at the distal enhancers, as
described previously (9, 10). Interestingly, however, no ER
recruitment was detected at the promoters of any of the near-
est neighboring genes. These results are consistent with long-
range activation by liganded ER from distal enhancers in-
volving, perhaps, a looping mechanism (9).
To substantiate our ChIP-chip results, as well as generate a
more detailed view of Pol II and ER occupancy at target
promoters, we performed ChIP-chip tiling across a 12-kb re-
gion surrounding the TSSs of four previously identified E2
target genes (i.e., the TFF1, EBAG9, c-Myc, and CASP7
genes) (Fig. 2D; also see Fig. S1A and D at the URL noted
above). This approach allowed us to distinguish more clearly
the sites of binding and nonbinding across the promoter re-
gions. For example, with the TFF1 gene, a clear peak of ER
recruitment was present at 0.5 kb upstream of the TSS in the
vicinity of a well-characterized ERE (1, 37), whereas the peak
of the Pol II recruitment was immediately downstream of the
TSS (Fig. 2D, top panel). In addition, a peak of Pol II was
observed 5 kb downstream of the TSS, coinciding with the
end of the TFF1 gene. This observation is consistent with
previous studies suggesting that Pol II temporarily pauses dur-
ing transcriptional termination (20). The other three promot-
ers also showed good correlations between previously charac-
terized EREs and the peaks of ER signal (e.g., the EBAG9
gene has a single ERE at 43 bp relative to the TSS) as well
as between known TSSs and the peaks of Pol II signal (e.g., the
c-Myc gene has three TSSs within its complex promoter region
[5]). These results provide an indication of the sensitivity and
fidelity of our ChIP-chip approach as well as information about
the detailed relationship between ER binding and Pol II
recruitment in response to E2.
Validation of Pol II and ER ChIP-chip results by qPCR.
To validate our ChIP-chip experiments and calculate the false-
positive error rates for our results, we performed standard
ChIP-qPCR for Pol II and ER on a set of randomly selected
target promoters identified in our ChIP-chip studies (Fig. 3A;
also see Fig. S2 at http://mbg.cornell.edu/cals/mbg/research
/kraus-lab/sm.cfm). Approximately 93 percent (25 out of 27) of
the Pol II binding sites identified by ChIP-chip also showed Pol
II binding by ChIP-qPCR. Similarly, about 91 percent (21 out
of 23) of the ER-binding sites identified by ChIP-chip showed
ER binding by ChIP-qPCR. Thus, our ChIP-chip experi-
ments had false-positive error rates of less than 10 percent,
which are similar to if not lower than those reported for other
ChIP-chip analyses.
Sequence analysis of ER-binding promoters. After charac-
terizing the binding of ER to a set of genomic sequences by
ChIP-chip, we assessed whether the ER-binding promoters
contain ERE-like sequences by using a statistical motif-search-
ing algorithm. Every DNA region on the microarray was que-
ried for the presence or absence of an ERE using a previously
determined ERE positional weight matrix (42), and the results
were expressed relative to ER binding status (Fig. 3B). The
likelihood of an ERE-like sequence occurring in one of the
ER-binding promoters was significantly higher (P  3.1 
105) than that found for promoter regions where no ER
binding was observed (Fig. 3B, top). Among the ER-binding
promoters, about half contained an ERE-like sequence (18 out
of 37 [P  1.5  104]) (Fig. 3B, bottom, and C, left). The
majority of the ER-binding promoters lacking an ERE-like
sequence contained one or more ERE half-sites (data not
shown). In total, about 17 percent (10 out of 58) of the direct
E2 target promoters on our array (as defined above) bind ER
and contain an ERE-like sequence.
In contrast, a similar approach using an AP-1 binding site
position weight matrix (24) revealed no difference in the oc-
currence of AP-1-like sequences between the ER-binding
and nonbinding promoters (Fig. 3B, top). However, for the
ER-binding promoters, AP-1-like sequences were enriched in
the promoters that did not contain an ERE-like sequence (P
0.038; Fig. 3B, bottom, and C, right). That is, for the set of
ER-binding promoters, the presence of an AP-1 site was
more likely in the absence of an ERE sequence. These results
implicate ER action at promoters through AP-1 (i.e., the
“tethering” pathway [28]) as a possible mechanism for E2-
dependent regulation of ERE-less promoters.
To connect our genomic binding data and bioinformatic
analyses to the biology of estrogen signaling through EREs and
AP-1 sites, we examined by gene-specific ChIP-qPCR the re-
cruitment of ER and c-Fos (a component of AP-1) to two
ER-binding promoters: an “ERE-only” promoter (i.e., the
EBAG9 gene; ERE-positive/AP-1 site-negative) (see also Fig.
S3 at http://mbg.cornell.edu/cals/mbg/research/kraus-lab/sm
.cfm) and an “AP-1-only” promoter (i.e., the UGT2B15 gene;
ERE-negative/AP-1 site-positive) (see Fig. S3 at the URL
noted above). As expected, both promoters showed recruit-
ment of ER, but only the UGT2B15 promoter showed re-
cruitment of c-Fos upon E2 treatment (Fig. 3D). These results
are consistent with the hypothesis that ER is recruited to the
ERE-negative/AP-1 site-positive UGT2B15 promoter through
tethering with components of the AP-1 complex. In transient
transfection reporter gene assays in MCF-7 cells with a
UGT2B15-luciferase construct, E2 treatment caused a four-
fold increase in luciferase activity (Fig. 3E). Furthermore, de-
letion of the AP-1 site in the UGT2B15 promoter dramatically
reduced reporter gene activity in the presence of E2 (Fig. 3E).
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FIG. 3. Gene-by-gene validation of RNA Pol II and ER promoter occupancy coupled with ER-binding sequence analyses. (A) Validation
by ChIP-qPCR of the ChIP-chip results for selected promoters from the estrogen-regulated promoter array. Results for RNA Pol II (upper graph)
and ER (lower graph) are shown. The empty and filled bars represent ChIP enrichment for untreated (-U) and E2-treated (-E) cells, respectively.
The class IIA, IIB, IIIA, IVA, and IVB promoters are as described for Fig. 2C. Each bar represents the mean standard error of the mean (SEM)
for at least three separate determinations. (B) Sequence analysis of ER-binding and nonbinding promoters. Motif-finding algorithms were used
to search for ERE- and AP-1-like sequences in the ER-binding and nonbinding promoters from the promoter microarray, as described in
Materials and Methods. (Top) Percentage of promoters in each category (i.e., ER binding or ER nonbinding) containing ERE- or AP-1-like
sequences; (bottom) analysis of the coexistence of ERE- and AP-1-like sequences in the set of ER-binding promoters. Relative ERE and AP-1
motif scores are plotted for each sequence. The dotted line represents the significance threshold (P  1.5  104) for determining ERE-like
sequences. A moving-average analysis was performed by calculating the average motif score of a sliding window of 13 regions from high to low
ERE scores. (C) Sequence logos for the ERE-like (left) and AP-1-like (right) elements identified in the ER-binding promoters are shown.
(D) ChIP-qPCR assay of ER recruitment (left graph) and c-Fos recruitment (right graph) to the EBAG9 promoter, an “ERE-only” (i.e.,
ERE-positive/AP-1 site-negative) promoter, and the UGT2B15 promoter, an “AP-1-only” (i.e., ERE-negative/AP-1 site-positive) promoter, in
response to E2. The empty and filled bars represent ChIP enrichment for untreated and E2-treated cells, respectively. Each bar represents the
mean  SEM for at least three separate determinations. Schematics of the EBAG9 and UGT2B15 promoters can be found in Fig. S3 at
http://mbg.cornell.edu/cals/mbg/research/kraus-lab/sm.cfm. (E) Luciferase reporter gene assays examining the role of a promoter-proximal AP-1
site in the E2-dependent regulation of the UGT2B15 promoter. UGT2B15-luciferase reporter constructs, with or without the promoter-proximal
AP-1 site (UGT2B15 and UGT2B15 AP-1, respectively), were transfected into MCF-7 cells and subsequently treated with E2 as described in Materials
and Methods. Each bar represents the mean  SEM for at least three separate determinations.
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These results confirm the predictions made based on the bioin-
formatic analyses and suggest that UGT2B15 is a novel ER/
AP-1-regulated gene. Interestingly, UGT2B15 encodes a
UDP-glucuronosyltransferase enzyme involved in the glucu-
ronidation of steroids and xenobiotics and may play a role in
reducing estrogen and androgen concentrations, thereby re-
ducing their signaling in breast cancer cells (22).
Relationships between Pol II, ER, acetylated histones, and
SRC at E2-regulated promoters. In addition to Pol II and
ER, E2-dependent transcriptional regulation involves the re-
cruitment of a variety of histone-modifying enzymes to target
promoters (27). One major group of histone-modifying en-
zymes is the histone acetyltransferases (HATs; e.g., p300, CBP,
and PCAF [p300/CBP-associated factor]), which establish spe-
cific patterns of lysine acetylation on the amino-terminal tails
of nucleosomal histones (19, 27, 39). Generally, histone acet-
ylation at promoters correlates with a more open chromatin
structure and increased transcriptional output (12). In many
cases, the recruitment of HATs by liganded ER is thought to
involve intermediary coactivators, such as the SRC proteins
(SRCs 1, 2, and 3, collectively referred to herein as “SRC”),
which bind simultaneously to both the liganded receptor and
HATs, thus directing the HATs to ER-bound genomic sites
(25, 32).
To examine potential relationships between Pol II, ER,
acetylated histones, and SRC, we performed additional ChIP-
chip analyses for SRC (using a panspecific anti-SRC antibody)
and acetylated H3 and H4 (using anti-acetylated H3 K9/14 and
anti-acetylated H4 K5/8/12/16 antibodies, respectively) with
our custom promoter array. Then, using Spearman rank cor-
relation analysis, we searched for possible correlations be-
tween pairwise combinations of Pol II, ER, AcH, and SRC.
The strongest and most significant correlations that we ob-
served were between Pol II and AcH (correlation coefficient
0.72983 [P  0.0001]) and between ER and SRC (correlation
coefficient 0.77549 [P 0.0001]) (Table 2). These results are
described in more detail below.
Pol II occupancy correlates with histone acetylation at the
promoters of E2-regulated genes. In our ChIP-chip analyses,
we identified a significant correlation between changes in Pol
II occupancy and AcH levels at promoters upon E2 treatment
(Table 2). The recruitment of Pol II correlated with increased
levels of AcH, and the release of Pol II correlated with de-
creased levels of AcH (Fig. 4A). These results were confirmed
for more than 25 promoters by ChIP-qPCR (Fig. 4B; also see
Fig. S4 at http://mbg.cornell.edu/cals/mbg/research/kraus-lab
/sm.cfm). In addition, the correspondence between Pol II oc-
cupancy and AcH levels at promoters was clearly evident in
ChIP-chip tiling assays with the TFF1, EBAG9, c-Myc, and
CASP7 genes (Fig. 4C; also see Fig. S1B and E at the URL
noted above). For all four genes, the AcH levels were elevated
in the proximal promoter region and increased upon E2 treat-
ment in a pattern very similar to the pattern of Pol II occu-
pancy. The correspondence between Pol II occupancy and
AcH levels was also evident for promoters apparently regu-
lated by a distal ER-binding enhancer (Table 1). Collectively,
our results indicate that the levels of AcH at the promoters of
E2-regulated genes correlate with Pol II occupancy and that
histone acetylation is likely to play a role in regulating the
expression of E2 target genes across the genome. Furthermore,
as described below, our results indicate that Pol II and AcH are
good markers for active promoters.
ER binding correlates with SRC recruitment at the pro-
moters of E2-stimulated genes. In our ChIP-chip analyses, we
also identified a significant correlation between ER binding
and SRC recruitment at the promoters of E2-stimulated genes
upon E2 treatment (Table 2). Although SRC was not located
at all ER-bound promoters, our results suggest that SRC
binding is dependent on ER binding, since the vast majority
of the SRC-bound promoters were also bound by ER (Fig.
5A and D; also see Fig. S5 at http://mbg.cornell.edu/cals/mbg
/research/kraus-lab/sm.cfm). Again, these results were con-
firmed for more than 25 promoters by ChIP-qPCR (Fig. 5B;
also data not shown). Interestingly, although some of the SRC-
recruiting promoters that we identified have been reported
previously in gene-specific assays (e.g., the TFF1, CAP2, and
CYP1B1 promoters [30]), we also identified and confirmed a
number of novel SRC target promoters (e.g., SLC27A2,
MMP2, PRUNE, and SERPINA1) where the recruitment of
SRC correlated with the recruitment of ER. A similar corre-
spondence between ER binding and SRC recruitment was
also evident in ChIP-chip tiling assays with the TFF1, EBAG9,
c-Myc, and CASP7 genes (Fig. 5C; also see Fig. S1C and F at
the URL noted above) and in ChIP-chip assays with distal
enhancers (Table 1), in that SRC binding was observed only in
regions where ER was bound.
Interestingly, SRC binding was not detected at the promot-
ers of E2-repressed genes (i.e., class IV, reduced Pol II upon
E2 treatment) irrespective of ER binding status (Fig. 5D).
These results were confirmed for a subset of the class IV
promoters (Fig. 5E; see ESR1, ID1, and BLNK). In addition to
the correlation between SRC and ER at the promoters of
E2-stimulated genes, a significant, but weaker, correlation be-
tween SRC occupancy and AcH levels was also observed (Ta-
ble 2; correlation coefficient 0.42857 [P 0.0257]). For more
than half of the promoters that we screened by ChIP-qPCR,
TABLE 2. Correlation analysis of factor binding and RNA expression upon E2 treatment
Gene
Correlation coefficient (P value) for indicated pairwise combinationa:
ER Pol II SRC AcH RNA
ER 1 0.40922 (0.0001) 0.77549 (0.0001) 0.34251 (0.0305) 0.2055 (0.0487)
Pol II 1 0.23582 (0.0494) 0.72983 (0.0001) 0.4546 (0.0001)
SRC 1 0.42857 (0.0257) 0.0244 (0.8805)
AcH 1 0.4458 (0.0001)
a Spearman’s rank correlation coefficients and P values are listed for all possible pairwise combinations of factor binding/histone modification upon E2 treatment.
The strongest correlations are shown in bold.
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E2-regulated SRC occupancy corresponded with AcH levels
(Fig. 4B, bottom, and 5B, bottom; also data not shown). These
results are consistent with the known role of SRC in recruiting
HATs to target genes (25, 32). Collectively, our results suggest
that although the E2-dependent recruitment of SRCs to acti-
vated promoters requires ER, promoter-bound liganded
ERs are not capable of recruiting SRCs at E2-repressed
genes in the same cells. Future studies will investigate the
mechanisms determining whether or not a promoter-bound
liganded ER can recruit SRCs.
Relationship of RNA expression to factor occupancy and
histone modification at E2-regulated promoters. To evaluate
the roles of factor recruitment and histone acetylation in the
transcription of E2 target genes, we performed a gene expres-
sion microarray analysis in MCF-7 cells in the presence or
absence of E2 treatment using Affymetrix U133A 2.0 microar-
rays (representing 14,500 well-characterized human genes).
A short treatment of 3 h was used to enrich for genes directly
regulated by E2 and not through secondary effects. The cell
growth and treatment conditions were similar to those used for
the ChIP-chip analyses. By use of stringent selection criteria
(P  0.05; regulation [n-fold], 2), 122 genes were identified
as stimulated by E2 and 95 genes were identified as inhibited
by E2 (Fig. 6A).
To determine if the regulation of gene expression by E2 was
associated with factor occupancy or histone acetylation at pro-
moters, we performed correlation analysis with the data from
our expression microarray and ChIP-chip experiments (Table
2). The strongest and most significant correlations with RNA
expression were Pol II recruitment (correlation coefficient 
0.45 [P  0.0001]) and AcH levels (correlation coefficient 
0.44 [P  0.0001]) (Fig. 6B; also see Fig. S6A at http://mbg
.cornell.edu/cals/mbg/research/kraus-lab/sm.cfm). These corre-
lations were even more pronounced for genes in classes I
through IV when gene expression was measured by qPCR (see
Fig. S6B at the URL noted above). The relationships between
Pol II occupancy, AcH levels, and gene expression held for
genes apparently controlled by distal EREs (Table 1). Inter-
estingly, although a weaker, but significant, correlation be-
tween ER recruitment and gene expression was observed
(correlation coefficient  0.21 [P  0.0487]), no significant
correlation between SRC recruitment and mRNA expression
FIG. 4. RNA Pol II occupancy correlates with histone acetylation at the promoters of E2-regulated genes. (A) Correlation between E2-
dependent RNA Pol II recruitment and histone H3 and H4 acetylation. The relative change in histone acetylation or Pol II occupancy is defined
as the log2 change (n-fold) upon E2 treatment as a percentage of the maximum log2 change (n-fold) observed for each factor. The correlation
coefficient is 0.73 (P  0.0001). All array elements with significant ChIP enrichment ratios (P  0.05) were included in the analysis. (B) Validation
by ChIP-qPCR of the ChIP-chip results for selected promoters from the estrogen-regulated promoter array. Results for RNA Pol II (upper graph;
black) and AcH (lower graph; blue) are shown. The class IIA, IIB, IIIA, IV, and IA promoters are as shown in Fig. 2C. Each bar represents the
mean  SEM for at least three separate determinations. (C) ChIP-chip tiling for the TFF1 and EBAG9 genes. Occupancy, expressed as ChIP
enrichment ratios (IP/input), for RNA Pol II and AcH throughout the indicated genomic region is shown in the absence (-U) or presence (-E)
of E2. “0” represents the TSS; regions upstream of the TSS are indicated by negative numbers.
5098 KININIS ET AL. MOL. CELL. BIOL.
 o
n
 January 14, 2015 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
FIG. 5. ER recruitment correlates with SRC recruitment to the promoters of E2-stimulated, but not E2-repressed, genes. (A) Correlation
between E2-dependent ER recruitment and SRC recruitment to gene promoters. The relative change in factor occupancy is defined as the log2
change (n-fold) in occupancy upon E2 treatment as a percentage of the maximum log2 change (n-fold) observed for each factor. The correlation
coefficient is 0.78 (P  0.0001). All array elements with significant ChIP enrichment ratios (P  0.05) were included in the analysis. (B) Validation
by ChIP-qPCR of the ChIP-chip results for selected promoters from the estrogen-regulated promoter array. Results for ER (upper graph; red)
and SRC (lower graph; green) are shown. The class IIA, IIB, IIIA, IV, and IA promoters are as shown in Fig. 2C. Each bar represents the mean SEM
for at least three separate determinations. (C) ChIP-chip tiling for the TFF1 and EBAG9 genes. Occupancy, expressed as ChIP enrichment ratios
(IP/input), for ER and SRC throughout the indicated genomic region is shown in the absence (-U) or presence (-E) of E2. “0” represents the
TSS; regions upstream of the TSS are indicated by negative numbers. (D) ChIP-chip data showing Pol II, ER, and SRC occupancy, as well as
AcH levels, for a set of E2-repressed promoters before and after E2 treatment. Data for all class IV promoters, as well as for some class IIA and
class IIIA promoters, are shown. The intensity of the color in each group indicates the strength of ChIP-chip signal, with white indicating no signal.
(E) Validation by ChIP-qPCR of the ChIP-chip results for selected promoters from panel D. The light- and dark-colored bars for each factor
indicate ChIP enrichment for untreated (-U) and E2-treated (-E) cells, respectively. Each bar represents the mean  SEM for at least three
separate determinations.
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was observed (Table 2). This latter result indicates that the
recruitment of SRC alone is not sufficient to predict the mode
of gene regulation across the set of E2-regulated genes.
To validate the expression microarray results and further
analyze the expression of genes where Pol II and/or ER
binding was observed (i.e., classes I through IV), we measured
RNA expression in MCF-7 cells by reverse transcription-qPCR
after 1 or 3 h of treatment with E2 (Fig. 6C; also see Fig. S6C
at the URL noted above). As expected, the genes in classes IIA
and IIB (i.e., genes showing Pol II recruitment to their pro-
moters upon E2 treatment) were stimulated by E2, whereas
genes in class IV (i.e., genes showing dismissal of Pol II from
their promoters upon E2) were inhibited by E2. Gene regula-
tion after a 3-h E2 treatment correlated more strongly with Pol
II recruitment and AcH levels than did gene regulation after a
1-h E2 treatment (see also Fig. S6C at the URL noted above).
Interestingly, all genes in class IA (i.e., genes showing ER
recruitment to promoters upon E2, but no Pol II binding) were
regulated by E2 (Fig. 6C). As noted above, for these genes, the
detection of Pol II may fall below the limit of sensitivity of our
ChIP-chip assay or, alternatively, Pol II may not be detected at
the promoters due to rapid movement into the body of the
gene. Finally, genes in class IIIA (i.e., genes showing ER
recruitment to promoters upon E2, and constitutively high
occupancy by Pol II) were also regulated by E2 (Fig. 6C),
suggesting that ER regulates the transcriptional activity of
constitutively bound Pol II at these promoters.
E2-dependent regulation of constitutively bound Pol II at
target promoters. To examine how E2 signaling may be regu-
lating the activity of constitutively bound Pol IIs that are
present at target promoters prior to E2 induction, we assayed
by ChIP-qPCR for the presence of ER, Pol II, and phospho-
Pol II (i.e., phospho-Ser2 in the heptapeptide repeat of the Pol
II C-terminal domain). We focused on two genes: the class IIA
TFF1 gene, which does not have a constitutively bound Pol II,
and the class IIIA CYP1B1 gene, which has a constitutively
bound Pol II. Specifically, we assayed 200 bp upstream and
downstream of the TSS as well as more than 1,400 bp down-
stream of the TSS. As expected, E2-dependent recruitment of
ER was observed for the upstream regions of both the TFF1
gene and CYP1B1 (Fig. 7A and B, top panels; 235 and 216
regions, respectively). The TFF1 gene showed little or no Pol
II at the promoter prior to E2 treatment but did show recruit-
ment of Pol II to the promoter, phosphorylation of Ser2, and
movement of Pol II into the body of the gene after E2 treat-
ment (Fig. 7A, middle two panels). In contrast, for CYP1B1,
Pol II was present at the promoter prior to E2 treatment but
was in a predominantly hypophosphorylated form (Fig. 7B,
middle two panels; 216). After E2 treatment, Pol II was
phosphorylated at Ser2 and moved into the body of the gene
(Fig. 7B, middle two panels; 214 and 1412). The Pol II and
Pol II phospho-Ser2 ChIP signatures that we observed with
CYP1B1 are consistent with the presence of a paused Pol II at
the promoter (6, 44). In fact, nuclear run-on experiments,
which measure the density of Pol II at specific regions of a gene
(34), confirmed the presence of a previously unidentified
paused Pol II in the CYP1B1 promoter region (L. J. Core, M.
Kininis, J. T. Lis, and W. L. Kraus, unpublished data).
FIG. 6. E2-dependent gene expression correlates with RNA Pol II recruitment to target promoters. (A) RNA expression analysis of MCF-7
cells in the presence or absence of a 3-h treatment with E2 by use of Affymetrix U133A 2.0 microarrays. Scatterplot presentation of normalized
signal for each gene on the microarray in E2-treated cells (y axis) plotted versus the signal for each gene from untreated cells (x axis). The blue
and red lines represent the twofold increase or decrease cutoffs for expression, respectively. Genes showing E2-dependent increases in expression
are in blue, whereas genes showing E2-dependent decreases in expression are in red. Genes regulated less than twofold by E2 are in black. (B) Correlation
between E2-dependent RNA Pol II recruitment and mRNA expression. The relative change in mRNA or Pol II occupancy is defined as the log2 change
(n-fold) upon E2 treatment as a percentage of the maximum log2 change (n-fold) observed for each factor. The correlation coefficient is 0.45 (P 0.0001).
All promoters showing significant changes (P  0.05) for RNA expression and RNA Pol II ChIP recruitment were included in the analysis. (C) Gene-
by-gene confirmation of expression microarray results. MCF-7 cells were treated with or without E2 for 1 h or 3 h, and then RNA was isolated and
analyzed by qPCR for genes in classes IA, IIA, IIB, IIIA, and IV (from Fig. 2C). The mRNA expression scale is shown.
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To explore the E2-dependent regulation of the CYP1B1
promoter-proximally paused Pol II in more detail, we com-
pared the localizations of NELF at the CYP1B1 and TFF1
promoters before and after E2 treatment, as monitored by ChIP
for the NELFA subunit. NELF is a coregulatory complex in-
volved in the establishment of paused Pol IIs at promoters (44).
Interestingly, in the absence of E2 treatment, we observed strong
binding of NELFA to the CYP1B1 promoter (i.e., the 216
probe) but not the TFF1 promoter, suggesting a role for the
NELF complex in establishing the paused Pol II at the CYP1B1
promoter (Fig. 7, bottom panels). After treatment with E2, we
observed a redistribution of NELFA, resulting in a reduction of
NELFA levels at the CYP1B1 promoter and an increase imme-
diately downstream of the TSS (Fig. 7B, bottom panel). This
redistributed pattern of NELFA is consistent with the known
roles of NELF in regulating the Pol II release from the promoter-
proximal pause and in controlling the magnitude of a rapid tran-
scriptional response (2, 44). Together, these results suggest that
liganded ER directs the release from pausing at the CYP1B1
promoter by triggering a redistribution of NELF.
Collectively, our results indicate that the CYP1B1 promoter
contains a constitutively bound promoter-proximally paused
Pol II in conjunction with NELF. Upon E2 treatment, the Pol
II becomes phosphorylated and is released from the promoter
to transcribe through the CYP1B1 gene. Using a similar ap-
proach based on our ChIP-chip data, we identified a number of
other E2-regulated genes, including the c-Myc and c-Fos
genes, which are also likely to have promoter-proximally
paused Pol IIs (data not shown). To our knowledge, this is the
first report of E2 signaling regulating the elongation activity,
and not the recruitment, of Pol II at target genes. The presence
of paused Pol IIs at E2-regulated promoters may allow for
rapid transcriptional responses upon E2 treatment.
DISCUSSION
In the studies described herein, we used ChIP-chip to exam-
ine the E2-regulated localization of Pol II, ER, SRC, and
AcH at a set of target promoters that control the expression of
more than half of the early E2-regulated transcriptome in MCF-7
FIG. 7. E2-dependent regulation of constitutively bound Pol II at target promoters. ChIP-qPCR was used to determine the occupancy by ER,
Pol II, Ser2-phosphorylated Pol II, and NELFA at the TFF1 (A) and CYP1B1 (B) promoters. The empty and filled/hatched bars represent ChIP
enrichment for untreated (-U) and E2-treated (-E) cells, respectively. “” and “” indicate the regions upstream and downstream of the TSS,
respectively. Each bar represents the mean  SEM for at least three separate determinations.
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cells. We defined a set of 58 direct E2 target genes based on
E2-dependent changes in Pol II promoter occupancy and gene
expression (i.e., class II, IV, and IIIA promoters) (see http://mbg
.cornell.edu/cals/mbg/research/kraus-lab/sm.cfm), as opposed to
inferences from bioinformatics and statistical analyses or correla-
tions with RNA expression alone. As noted above, many of these
direct E2 target genes exhibit interesting modes of regulation and
biological activities, some of which may be relevant to onset
and proliferation of breast cancers (e.g., UGT2B15, CYP1B1,
and PRUNE; references 17, 22, and 47).
Our ChIP-chip experiments extend beyond previous ER
genomic localization experiments by (i) examining the ligand-
dependent localization of a non-DNA-binding nuclear recep-
tor cofactor (i.e., SRC), (ii) examining the genomic location of
four different types of factors simultaneously (i.e., ER [a
DNA-binding factor], SRC [a non-DNA-binding coregulator],
histone acetylation [a histone mark], and Pol II), (iii) deter-
mining the patterns of localization in both the presence and
the absence of E2, and (iv) correlating genomic localization
with functional output, namely, Pol II recruitment and tran-
scription from target promoters. Our results have revealed
global features of E2-regulated gene expression and allowed us
to classify the estrogen-regulated promoters in MCF-7 cells
based on factor binding, histone modification, and transcrip-
tional output. Furthermore, the examination of both E2-
treated and untreated conditions has revealed novel aspects of
ligand-regulated gene expression by ER and provided new
mechanistic insights. Finally, our bioinformatic analyses cou-
pled with gene-specific ChIP-qPCR have allowed us to identify
novel genes likely regulated by ER through AP-1 and link our
results to the biology of estrogen signaling through the ER/
AP-1 tethering pathway (Fig. 3D and E). A growing body of
published genomic analyses indicates that groups of genes
share a limited number of general regulatory mechanisms that
control their expression (4, 8, 26). Our studies simultaneously
examining the genomic localization of four different factors
have allowed us to reveal these common patterns and explore
the regulatory mechanisms that they represent.
Combinatorial ChIP-chip analyses reveal global features of
E2-regulated gene expression. Our ChIP-chip analyses have
revealed some previously unrecognized global features of E2-
regulated gene expression, which are likely to extend to steroid
hormone-regulated gene expression in general. First, we found
a strong positive correlation between occupancy by Pol II and
the levels of AcH (Table 2 and Fig. 4). This finding fits well
with the observation that acetylation of H3 and H4 is generally
associated with a more open, transcriptionally permissive chro-
matin structure (12) and has been implicated in gene regula-
tion by many different nuclear receptors (19, 27). Second, we
found a strong positive correlation between the E2-dependent
recruitment of ER and the recruitment of SRC at the pro-
moters of E2-stimulated, but not E2-repressed, genes (Table 2
and Fig. 5A, B, and C). SRC proteins bind directly to liganded
ER and play an important role in recruiting histone-modify-
ing coactivators, such as p300, CBP, PCAF, CARM1 (coacti-
vator-associated arginine methyltransferase 1), and PRMT
(protein arginine N-methyltransferase) (19, 32). In this regard,
we also observed a significant positive correlation between
SRC occupancy and AcH levels, consistent with the known role
of SRC in recruiting HATs to target promoters (19, 32). Note,
however, that the recruitment of SRC alone is not sufficient to
predict the mode of gene regulation across the set of E2-
regulated genes. Third, we found that for the set of ER-
binding promoters, the presence of an AP-1 site was more
likely in the absence of an ERE sequence (Fig. 3B), a result
consistent with recent bioinformatic and ChIP-chip analyses
(10). ER action through DNA-bound AP-1 (i.e., Fos/Jun
heterodimers in the “tethering” pathway [28]) represents an
alternate mechanism for the E2-dependent regulation of ERE-
less promoters. Finally, as discussed in more detail in the next
section, we found that many direct E2 target genes contain
ER-binding sites within their proximal promoter regions.
Many direct E2 target genes contain ER-binding sites
within their proximal promoter regions. A recent study using
genome-wide ER and Pol II ChIP-chip in E2-treated MCF-7
cells, as well as microarray analyses of E2-dependent gene
expression, concluded that only a small percentage of E2-
regulated genes are regulated by ER binding to the promoter-
proximal region, with the rest being regulated by ER binding
at distal enhancers (10). This study, however, did not include
an untreated (i.e., E2) condition, so the role of E2 in regu-
lating Pol II binding could not be assessed directly. A more
direct approach to study E2-regulated transcription is to limit
the analysis to confirmed direct E2 target genes (i.e., genes
showing E2-dependent changes in Pol II promoter occupancy
and gene expression), such as those in classes II, IV, and IIIA
in our analyses. In this regard, we found that about 36 percent
of these direct E2 target genes (21 out of 58) show ER
binding within a 1-kb fragment encompassing the proximal
promoter (Fig. 1C and 2C and associated text; also see the
URL noted above). Thus, a considerably higher percentage of
direct E2 target genes may contain promoter-proximal ER-
binding sites than previously suggested. In this regard, a recent
study using sensitive ChIP DNA selection and ligation tech-
nology identified a fraction of ER-binding promoters consid-
erably higher than that identified in previous studies (29).
Interestingly, about half of the promoter-proximal ER-bind-
ing sites that we identified contain an ERE-like sequence,
whereas the other half contain a variety of other potential
factor binding elements, including AP1-binding sites and half
EREs (Fig. 3B, C, and D and associated text). The role of ER
binding to distal enhancers has yet to be determined, although
results with estrogen and androgen receptor suggest that prox-
imal and distal enhancers may collaborate though a looping
mechanism (9, 48).
ChIP-chip analyses with both untreated and E2-treated
cells reveal new mechanistic insights into E2-regulated gene
expression. Previous ER ChIP-chip analyses with MCF-7
cells examined the genomic localization of ER and Pol II in
the presence, but not the absence, of E2 (9, 10, 29, 31). In our
ChIP-chip experiments, we examined both the untreated and
E2-treated conditions during the genomic discovery phase,
which allowed us to examine on a global scale the various
mechanisms controlling E2-regulated transcription. Specifi-
cally, comparisons between the untreated and E2-treated con-
ditions in MCF-7 cells allowed us to identify the following: (i)
a set of promoters constitutively bound by ER (Fig. 2A), (ii)
a set of E2-repressed genes with low occupancy by SRC (Fig.
5D and E), and (iii) a set of E2-regulated genes with consti-
tutively bound and possibly promoter-proximally paused Pol
5102 KININIS ET AL. MOL. CELL. BIOL.
 o
n
 January 14, 2015 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
IIs (Fig. 7A and B). Thus, our genomic analyses have yielded
new information about E2-dependent gene-specific regulatory
mechanisms and allowed us to classify E2-regulated genes
based on these modes of regulation.
The class IV genes from our analysis represent a set of direct
E2-repressed target genes that were revealed only by compar-
ing theE2 andE2 conditions. For these genes, Pol II leaves
the promoter and expression is reduced upon E2 treatment
(Fig. 5D and E and 6C). Although E2 acting through ER has
historically been associated with the stimulation of gene tran-
scription, recent microarray expression studies have indicated
that more than half of the E2-regulated transcriptome may be
repressed in response to E2, depending on the cell type and
length of treatment (18, 33, 38). Our results have provided new
insights into the underlying mechanisms of repression, namely,
the absence of SRC binding at E2-repressed genes. As noted
above, SRC proteins play an important role in recruiting the
histone-modifying enzymes that help to promote the formation
of more open, transcriptionally permissive chromatin (19, 32).
In the absence of SRC recruitment, one would expect the
chromatin to remain closed and transcriptionally repressed. In
this regard, a recent detailed analysis of CCNG2, a class IV
gene in our studies, showed that E2-dependent repression of
the gene is associated with the recruitment of the nuclear
receptor corepressor NCoR and the histone deacetylase 1 (46).
The lack of SRC recruitment to the class IV genes is striking
and suggests that E2-dependent SRC recruitment is not com-
patible with transcriptional repression. The means by which
E2-bound ER fails to bind and recruit SRC to specific re-
pressed genes, while at the same time actively recruiting SRC
to stimulated genes in other regions of the genome, is an open
question that will be addressed in future studies.
Comparison of the E2 and E2 conditions also revealed a
set of genes that are likely to have promoter-proximally paused
Pol IIs at their promoters in the absence of E2 treatment.
These include promoters with elevated levels of Pol II prior to
E2 treatment that either stay the same (e.g., class III) or
increase (e.g., class II) upon E2 treatment (Fig. 1C). CYP1B1
is one promoter that shows some of the hallmarks of a paused
Pol II, namely, elevated Pol II and NELF levels at the pro-
moter before signal induction and an increase in Pol II Ser2
phosphorylation upon release from pausing after signal induc-
tion. The establishment of a paused Pol II at a target promoter
involves a variety of factors, including NELF, a multisubunit
factor (44). Interestingly, a recent study has shown that
COBRA1 (cofactor of BRCA1 [breast cancer-associated protein
1]), an integral subunit of NELF, interacts with ER and
modulates the transcription of E2 target genes (2). The activity
of COBRA1 with ER at a promoter containing a paused Pol
II, however, has not yet been examined. Although a small
number of signal-regulated promoters with paused Pol IIs in
mammalian cells have been identified and characterized, this
mechanism of transcriptional regulation has not previously
been associated with E2-regulated genes. The presence of a
paused Pol II may provide a means by which cells can initiate
a rapid transcriptional response to E2. In the case of CYP1B1,
which encodes a cytochrome P450 monooxygenase that metab-
olizes E2 and has been implicated in breast and endometrial
carcinogenesis (47), a paused Pol II may be part of a rapid
metabolic feedback response in E2 target tissues. Future stud-
ies will determine which factors are involved in the activation
of promoter paused Pol IIs by E2 signaling and the biological
significance of this mode of regulation.
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